Industry News

IHF to Launch Geneva Centre of Healthcare Leadership for Sustainability

By HospiMedica International staff writers
06 Dec 2021

Illustration

The International Hospital Federation (IHF; Geneva, Switzerland) is preparing to launch the Geneva Centre of Healthcare Leadership for Sustainability (the Centre) in 2022 in response to the need for hospitals and healthcare services to address climate change.


As the urgent messages of the UN Climate Change Conference (COP26) are reflected on across the globe, hospital leaders are increasingly aware of their responsibility to advance the sustainability agenda. Research shows that if the world’s healthcare sector were a country, it would be the fifth-largest emitter of carbon emissions on the planet (The Lancet, Commission on Climate Change, 2009).


At the 44th World Hospital Congress held in Barcelona, Spain in November, sustainability was a key theme amongst delegates from around the world. Healthcare leaders and patients share the goal to make reducing climate impact a priority. However, this is a long-term challenge for the healthcare sector that will likely require multi-year commitments and the transformation of almost every aspect of how hospitals operate. There are currently few common standards within the industry, leading to different approaches and measurements which prevent comparisons and benchmarking. The Centre’s global reach and impact will build awareness and promote action among healthcare leaders, and provide capacity building to anchor leadership for sustainability into the healthcare sector for the long-term:


• Establishing the message and communicating the urgency for action, and the call to lead.


• Building the platform for initiatives, communication, programmes, and collective action.


• Constructing long-term support to keep the work ongoing for the decade ahead.


Recruitment is underway for the Centre’s core team, to be headquartered in Geneva, Switzerland. As well as appointing an experienced Executive Director, initial hires will include skilled professionals for communication, education and training, and project management. The Centre will be established with the support of a private donor based in Geneva, channeled through the Geneva University Hospitals (HUG), who are a member of the IHF.


“Hospital leaders are increasingly aware of this need for action on climate change,” explained Ronald Lavater, CEO of the IHF. “However, without adequate support for the development of new leadership competencies in sustainability, progress will come too slowly. With its global network of health authorities and hospital leaders, as well as strong links to institutions and NGOs within the international Geneva landscape, the International Hospital Federation is uniquely positioned to take a leadership role for this work.”


“We are at a pivotal moment to act against a global crisis,” said Bertrand Levrat, Director-General of the HUG and IHF Governing Council Member. “The Geneva Centre of Healthcare Leadership for Sustainability provides a timely opportunity to guide hospitals leaders on the agenda of climate change. Responding to the sustainability agenda is a long-term challenge for the healthcare sector, and hospital leaders cannot fully address this issue without adequate support.”


Related Links:
The International Hospital Federation 



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

21 Jan 2022
Global Immunofluorescence Assay (IFA) Market to Surpass USD 4 Billion by 2028 Due to Growing Burden of Infectious Diseases
The global immunofluorescence assay (IFA) market is expected to reach USD 4.01 billion by 2028, driven by the increasing global healthcare burden of chronic and infectious diseases, rising application of immunofluorescence assays in clinical diagnostics and research, and growing investments and expenditure in healthcare sector.
Read More
21 Jan 2022
Global Digital X-Ray Systems Market to Be Driven by AI-Based Systems and Robotic Devices
The global digital X-ray systems market was valued at USD 11.74 billion in 2020 and is expected to grow at a CAGR of 7.45% during the forecast period 2021 to 2026, due to the rising number of cancer patients and increasing cases of orthopedic diseases/tumors, cardiovascular diseases (CVD), pneumonia, and dental disorders, among others.
Read More
20 Jan 2022
Illumina and Boehringer Ingelheim Partner to Develop Companion Diagnostics (CDx) for Cancer Treatment
Illumina Inc. (San Diego, CA, USA) has entered into a partnership with Boehringer Ingelheim (Ingelheim am Rhein, Germany; www.boehringer-ingelheim.com) to develop companion diagnostics (CDx) for several programs in the latter’s oncology pipeline. The partnership aims to accelerate the development of therapy selection and precision medicines for patients with advanced cancer.
Read More
20 Jan 2022
Thermo Fisher and Oncocyte to Jointly Develop IVD Test Kits and Companion Diagnostic Tests in Precision Oncology
Oncocyte Corporation (Irvine, CA, USA) has entered into a development and co-marketing agreement for two distributed in vitro diagnostic (IVD) assays on Thermo Fisher Scientific’s (Waltham, MA, USA) Ion Torrent Genexus System. The agreement also grants Oncocyte rights to develop future companion diagnostics on the Genexus System.
Read More
18 Jan 2022
Global Coagulation Analyzers Market Driven by Growing Awareness About Timely Diagnosis of Blood Clots
The global coagulation analyzers market is expected to reach USD 11.7 billion by 2028, driven by the increasing understanding of blood clots and the fact that they can be avoided with early detection.
Read More
17 Jan 2022
Mobile C-Arms Market to Surpass USD 1.6 Billion in 2027 Due to Growing Preference for Minimally Invasive Surgeries
The global mobile C-arms market is expected to grow at a CAGR of 5.2% from USD 1.07 billion in 2019 to USD 1.61 billion in 2027, driven primarily by an increase in the global geriatric population, rising burden of chronic and acute diseases across the world, increasing volumes of orthopedic, cardiac, neurological, and oncological surgical procedures, and growing preference for minimally invasive surgeries.
Read More
14 Jan 2022
Medlab Middle East to Reveal Latest Innovations and Technologies in Mobile Labs for COVID-19 Testing
The latest technology and innovation in the global fight against COVID-19 and beyond will be on show at the next edition of Medlab Middle East when it returns to the Dubai World Trade Center from 24-27 January 2022 with mobile molecular testing and diagnosis stations, or ‘laboratories on wheels’, from companies such as Seegene, Inc. (Seoul, Korea) taking center stage.
Read More
13 Jan 2022
Global Coagulometers Market to Be Driven by Rising Prevalence of Blood Disorders
The global coagulometers market is being driven by a rise in the incidence and prevalence of blood disorders such as hemophilia that is fueling the demand for more diagnostic tools.
Read More
11 Jan 2022
Medlab Middle East to Return as Standalone Event in 2023
Informa Markets (London, UK), organizers of Medlab Middle East, have announced that the MENA region’s leading exhibition for the laboratory industry will return to a standalone event in 2023.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions